Frankfurt Stock Exchange · Financial Services
Invest in MOLOGEN Lifescience stock from India
Indian and foreign residents can buy MOLOGEN Lifescience (U1DA) shares directly through Paasa.
By Paasa · Updated
MOLOGEN Lifescience at a glance
- Price
- €2.80+€0.00 (0.00%)
- Market cap
- €220.50K
- Day range
- €2.80 – €2.80
- P/E
- 0.00
- Dividend yield
- None
- Volume
- 2.00
- 1 month
- +0.00%
- 6 months
- +0.00%
- YTD
- +7.69%
- 1 year
- +7.69%
- 5 years
- -67.06%
MOLOGEN Lifescience statements, FY2017–FY2021
| Fiscal year | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|
| Revenue | €45.1K | €0.0 | €0.0 | €15.0K | €97.0K |
| Gross profit | €45.1K | −€231.0 | −€268.0 | −€78.7K | €98.2K |
| Operating income | €45.1K | −€166.6K | −€183.0K | −€200.3K | €34.7K |
| Net income | −€81.5K | −€8.8M | €347.1K | −€426.0K | −€574.8K |
| Earnings per share | €0.00 | −€111.34 | €4.41 | −€5.41 | −€56.07 |
| EBITDA | €0.0 | −€8.8M | €351.9K | −€399.1K | −€574.7K |
| Total assets | €417.9K | €306.2K | €8.7M | €8.8M | €2.0M |
| Total debt | €0.0 | €16.6 | €67.7K | €2.1 | €0.0 |
| Cash and short-term investments | €7.3K | €0.0 | €179.5 | €139.2K | €19.9K |
| Shareholders' equity | €0.0 | −€287.4K | €8.5M | €8.1M | €1.3M |
| Operating cash flow | €0.0 | €462.0 | €536.0 | €0.0 | €0.0 |
| Free cash flow | €0.0 | €462.0 | €536.0 | €0.0 | €0.0 |
| Capital expenditure | €0.0 | €0.0 | €0.0 | €0.0 | €0.0 |
Fiscal years as reported, the latest ending 31 Dec 2021. Figures in EUR; a dash means the provider reported nothing for that line.
How to invest in MOLOGEN Lifescience from India
Step 1
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Step 2
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit, and Interactive Brokers converts the dollars to EUR when you buy.
Step 3
Search U1DA and buy
Find MOLOGEN Lifescience by name or by its ticker, U1DA, and place your order.
Why invest in MOLOGEN Lifescience from India
What MOLOGEN Lifescience does
Finchain Capital Partners AG functions as an investment firm, concentrating its capital deployment on early-stage companies, specifically during their seed, Series A, and Series B funding rounds. The company was established on February 27, 2015, and is based in Dusseldorf, Germany. MOLOGEN Lifescience operates in the Asset Management industry within the Financial Services sector.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Frequently asked questions
Can I buy MOLOGEN Lifescience stock from India?
Yes. Indian residents and NRIs can buy MOLOGEN Lifescience (U1DA) shares directly through Paasa. MOLOGEN Lifescience is listed on the Frankfurt Stock Exchange, in the Asset Management industry. Your money leaves India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name at Interactive Brokers.
What tax do I pay in India when I sell MOLOGEN Lifescience shares?
In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the EUR/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.